Market Research Logo

Saudi Arabia Pharmaceuticals and Healthcare Report Q2 2016

Saudi Arabia Pharmaceuticals and Healthcare Report Q2 2016

BMI View: High per capita spending on pharmaceuticals and a rising burden of chronic diseases willsupport long-term pharmaceutical growth in Saudi Arabia. However, a prolonged period of subdued oilprices may see Saudi Arabia cut back on high value drug spending - posing a risk to innovativedrugmakers. Our outlook for the country's healthcare sector is a positive one. As such, the government'sfocus on healthcare will remain a priority, owing to the sensitive nature of the sector and its politicalimportance. However, cost-containment measures will be encouraged, and over the long-term, the privatesector will play an increasingly important role in the provision of healthcare in Saudi Arabia.

Headline Expenditure Projections

Pharmaceuticals: SAR31.75bn (USD8.46bn) in 2015 to SAR35.32bn (USD9.42bn) in 2016; +11.3% inboth local currency and US dollar terms. Forecast unchanged from Q116.

Healthcare: SAR113.11bn (USD30.16bn) in 2015 to SAR123.31bn (USD32.88bn) in 2016; +9.0% inboth local currency and US dollar terms. Forecast in line with Q116.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Saudi Arabia 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Saudi Arabia 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Saudi Arabia 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Saudi Arabia 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Saudi Arabia 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Saudi Arabia 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Saudi Arabia 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Saudi Arabia 2012-2020)
OTC Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Saudi Arabia 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Saudi Arabia 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Saudi Arabia 2014-2020)
Industry Risk Reward Index
Middle East and Africa Risk/Reward Index - Q2 2016
Saudi Arabia Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Saudi Arabia 2010-2015)
Table: Healthcare Personnel (Saudi Arabia 2010-2015)
Table: Healthcare Activity (Saudi Arabia 2010-2015)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
GlaxoSmithKline
Sanofi
SPIMACO
TABUK Pharmaceutical Manufacturing
Novartis
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Saudi Arabia 1990-2025)
Table: Key Population Ratios (Saudi Arabia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Saudi Arabia 1990-2025)
Table: Population By Age Group (Saudi Arabia 1990-2025)
Table: Population By Age Group % (Saudi Arabia 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report